We use cookies on accura.dk

accura.dk uses cookies to improve the user-friendliness and functionality. By using our website, you consent to our use of cookies. Read more about cookies at accura.dk. Enjoy.

Read more about our cookie policy and instructions to delete cookies

;

Biogen sells its Danish company to FUJIFilm in billion-kroner transaction


;

Caseinfo

FUJIFilm has acquired Biogen's Danish biotechnology manufacturing company at a price of USD 890m, corresponding to approx. DKK 6bn.

Biogen is one of the world's largest global biotechnology companies and is leading within innovative scientific research.

Biogen's Danish company is located in Hillerød and consists of extensive, high-technology manufacturing, laboratory and logistics facilities. The company employs approx. 800 persons who will all continue under FUJIFilm's ownership.

FUJIFilm will e.g. use the factory in Hillerød to manufacture commercial products for Biogen and other biotechnology companies.

FUJIFilm is based in Tokyo and is one of the largest operating companies in FUJIFilm Holdings. The company develops solutions within a broad portfolio of chemical, mechanical, optical and visual technologies.

The transaction is conditional on the usual public authority approvals.

Kåre Stolt, Morten Bruus, Laurits Schmidt Christensen, Noel Strange-Obel Johansen, Poul Erik Lytken, Lærke Louise Jeppsen, Peter Brask Tind, Charlotte Fornø, Madeeha Ali, Christoffer Ege Andersen, Mathias Møller Jensen and Nikolaj Grønvald Hansen advised Biogen in connection with the sale.


Kontakt

Noel Strange-Obel Johansen
Noel Strange-Obel Johansen

Associate Partner, Attorney-at-Law

Phone: +45 3945 2911
Mobile: +45 3078 6711
noel.johansen@accura.dk


Accura's recent cases

We advise in connection with the largest and most complex transactions on the market.

Read a selection of our cases here.

Accura's recent cases

Accura's M&A Team

Accura's M&A Team